{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:45:04Z","timestamp":1792622704885,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.hoc.2024.11.005","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T20:39:55Z","timestamp":1734467995000},"page":"347-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patient-Reported Outcomes in Radiation Oncology"],"prefix":"10.1016","volume":"39","author":[{"given":"Erin","family":"McCammack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Alcorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.hoc.2024.11.005_bib1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/1062860617723707","article-title":"The future of quality improvement in breast cancer: patient-reported outcomes","volume":"32","author":"Sharma","year":"2017","journal-title":"Am J Med Qual"},{"issue":"23","key":"10.1016\/j.hoc.2024.11.005_bib2","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1001\/jama.288.23.3027","article-title":"Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial","volume":"288","author":"Detmar","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.hoc.2024.11.005_bib3","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1200\/JCO.2004.06.078","article-title":"Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial","volume":"22","author":"Velikova","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.hoc.2024.11.005_bib4","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1245\/s10434-018-6616-1","article-title":"Patient-reported outcomes for breast cancer","volume":"25","author":"Tevis","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2024.11.005_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.2017.7156","article-title":"Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment","volume":"318","author":"Basch","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.hoc.2024.11.005_bib6","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.3390\/curroncol29050251","article-title":"Patient-reported outcomes measurement in radiation oncology: interpretation of individual scores and change over time in clinical practice","volume":"29","author":"Kwon","year":"2022","journal-title":"Curr Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2024.11.005_bib7","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/NCC.0b013e318269040f","article-title":"Comparison between patient-reported and clinician-observed symptoms in oncology","volume":"36","author":"Xiao","year":"2013","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.hoc.2024.11.005_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1200\/EDBK_159514","article-title":"Patient-reported outcomes in cancer clinical trials: measuring symptomatic adverse events with the national cancer institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"36","author":"Kluetz","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"32","key":"10.1016\/j.hoc.2024.11.005_bib9","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1200\/JCO.2007.11.3803","article-title":"Patient-reported outcomes supporting anticancer product approvals","volume":"25","author":"Rock","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.hoc.2024.11.005_bib10","doi-asserted-by":"crossref","first-page":"dju244","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.hoc.2024.11.005_bib11","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/pbc.24463","article-title":"The first step to integrating the child\u2019s voice in adverse event reporting in oncology trials: a content validation study among pediatric oncology clinicians","volume":"60","author":"Reeve","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.005_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.semradonc.2022.01.010","article-title":"Integrating the patient\u2019s voice in toxicity reporting and treatment decisions for breast radiotherapy","volume":"32","author":"Alcorn","year":"2022","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.005_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11060-006-9135-z","article-title":"Validation of the M.D. Anderson symptom inventory brain tumor module (MDASI-BT)","volume":"80","author":"Armstrong","year":"2006","journal-title":"J\u00a0Neuro Oncol"},{"issue":"10","key":"10.1016\/j.hoc.2024.11.005_bib14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hed.20602","article-title":"Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module","volume":"29","author":"Rosenthal","year":"2007","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.hoc.2024.11.005_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1634\/theoncologist.2010-0193","article-title":"Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory","volume":"16","author":"Mendoza","year":"2011","journal-title":"Oncol"},{"issue":"8","key":"10.1016\/j.hoc.2024.11.005_bib16","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/cncr.24920","article-title":"Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI)","volume":"116","author":"Wang","year":"2010","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.hoc.2024.11.005_bib17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","article-title":"Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer","volume":"56","author":"Wei","year":"2000","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.005_bib18","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2024.11.005_bib19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF00449426","article-title":"A\u00a0validation study of the domains of the core EORTC Quality of Life Questionnaire","volume":"2","author":"Niezgoda","year":"1993","journal-title":"Qual Life Res"},{"key":"10.1016\/j.hoc.2024.11.005_bib20","series-title":"Designing, implementing and interpreting patient reported outcomes in Clinical investigation","author":"Gillespie","year":"2024"},{"issue":"7","key":"10.1016\/j.hoc.2024.11.005_bib21","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/1078-0432.CCR-15-2035","article-title":"Focusing on core patient-reported outcomes in cancer clinical trials: symptomatic adverse events, physical function, and disease-related symptoms","volume":"22","author":"Kluetz","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.hoc.2024.11.005_bib22","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1016\/S2352-3026(18)30051-6","article-title":"Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies","volume":"5","author":"Thanarajasingam","year":"2018","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.hoc.2024.11.005_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12955-016-0426-6","volume":"14","author":"Bennett","year":"2016","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"10.1016\/j.hoc.2024.11.005_bib24","doi-asserted-by":"crossref","first-page":"e2424793","DOI":"10.1001\/jamanetworkopen.2024.24793","article-title":"Patient-reported outcome measures in cancer care: an updated systematic review and meta-analysis","volume":"7","author":"Balitsky","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.005_bib25","first-page":"225","article-title":"Randomized trials with quality of life endpoints: are doctors\u2019 ratings of patients\u2019 physical symptoms interchangeable with patients\u2019 self-ratings?","volume":"6","author":"Stephens","year":"1997","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"issue":"24","key":"10.1016\/j.hoc.2024.11.005_bib26","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/jnci\/djr485","article-title":"Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival","volume":"103","author":"Quinten","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2024.11.005_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.radonc.2021.03.020","article-title":"How do patient-reported outcomes compare with clinician assessments? A prospective study of radiation dermatitis in breast cancer","volume":"159","author":"Behroozian","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.hoc.2024.11.005_bib28","first-page":"34","article-title":"Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer","volume":"31","author":"Kowalchuk","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2024.11.005_bib29","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jamaoncol.2022.0114","article-title":"Identifying patients whose symptoms are underrecognized during treatment with breast radiotherapy","volume":"8","author":"Jagsi","year":"2022","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2024.11.005_bib30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2024.11.005_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejca.2016.11.006","article-title":"Structural distress screening and supportive care for patients with lung cancer on systemic therapy: a randomised controlled trial","volume":"72","author":"Geerse","year":"2017","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.hoc.2024.11.005_bib32","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2024.11.005_bib33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ijrobp.2016.08.003","volume":"97","author":"Truong","year":"2017","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.hoc.2024.11.005_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/PROM.S156279","article-title":"The importance of patient-reported outcomes in clinical trials and strategies for future optimization","volume":"9","author":"Mercieca-Bebber","year":"2018","journal-title":"Patient Relat Outcome Meas"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.005_bib35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jamaoncol.2015.0530","article-title":"Patient-reported outcomes in cancer drug development and US regulatory review: perspectives from industry, the Food and drug administration, and the patient","volume":"1","author":"Basch","year":"2015","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2024.11.005_bib36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijrobp.2023.06.020","article-title":"Improving characterization and management of acute radiation skin toxicity across skin tones in breast cancer","volume":"117","author":"Mushonga","year":"2023","journal-title":"Int J Radiat Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.005_bib37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/17407745221077691","article-title":"The PROTEUS-Trials Consortium: optimizing the use of patient-reported outcomes in clinical trials","volume":"19","author":"Snyder","year":"2022","journal-title":"Clin Trials"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.005_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s41687-023-00670-z","article-title":"Evaluating medical students\u2019 knowledge of patient-reported outcomes and the impact of curriculum intervention in consecutive cohorts","volume":"7","author":"Florentino","year":"2023","journal-title":"J\u00a0Patient-Rep Outcomes"},{"issue":"9","key":"10.1016\/j.hoc.2024.11.005_bib39","doi-asserted-by":"crossref","first-page":"e012863","DOI":"10.1136\/bmjopen-2016-012863","article-title":"Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in UK cancer clinical trials: the EPiC study protocol","volume":"6","author":"Ahmed","year":"2016","journal-title":"BMJ Open"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858824001503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858824001503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T14:42:14Z","timestamp":1750862534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858824001503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0889858824001503"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2024.11.005","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-Reported Outcomes in Radiation Oncology","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2024.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}